Hearn J. Cho
Chief Medical Officer
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Hearn J. Cho as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 01:54 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT06171685 · MMRC Horizon One: RRMM (MMRC-099)Multiple Myeloma Research Consortium · active not recruiting · Relapse Multiple Myeloma, Refractory Multiple Myeloma
- Ph1/Ph2NCT04150965 · Immuno-Oncology Drugs Elotuzumab, Anti-LAG-3 and Anti-TIGITMultiple Myeloma Research Consortium · terminated · Multiple Myeloma, Relapsed Refractory Multiple Myeloma · principal investigator
- Ph1/Ph2NCT03732703 · Myeloma-Developing Regimens Using Genomics (MyDRUG)Multiple Myeloma Research Consortium · completed · Relapsed Refractory Multiple Myeloma
- N/ANCT03657251 · MMRF CureCloud Research InitiativeMultiple Myeloma Research Foundation · terminated · Multiple Myeloma
- Ph1NCT01380145 · MAGE-A3 Protein + AS15 as Consolidation for Multiple Myeloma Patients Undergoing Autologous Stem Cell TransplantationLudwig Institute for Cancer Research · completed · Multiple Myeloma
- Ph2NCT00843310 · Combination of Revlimid, Melphalan and Dexamethasone as First Line Treatment for Multiple MyelomaNYU Langone Health · terminated · Multiple Myeloma
Grants
NIH projects from RePORTER, fetched 2026-11-12 01:54 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 2 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 01:54 UTC. The ranking covers the 200 most relevant of 106 PubMed records, and a shared surname and initials can bring in a namesake. All 106 on PubMed
- 696 citationsRCR 15.3
- Determinants of Response and Intrinsic Resistance to PD-1 Blockade in Microsatellite Instability-High Gastric Cancer.Cancer Discov · 2021203 citationsRCR 8.7
- 156 citationsRCR 19.7
- 152 citationsRCR 3.8
- 146 citationsRCR 4.7
- 106 citationsRCR 3.4
- 100 citationsRCR 6.3
- A prospective randomized study comparing arthroscopic single-bundle and double-bundle posterior cruciate ligament reconstructions preserving remnant fibers.Am J Sports Med · 201192 citationsRCR 5.0
- Effect of intravenously administered iron sucrose on the prevention of anemia in the cervical cancer patients treated with concurrent chemoradiotherapy.Gynecol Oncol · 200783 citationsRCR 2.7
- Trait sensitivity to social disconnection enhances pro-inflammatory responses to a randomized controlled trial of endotoxin.Psychoneuroendocrinology · 201564 citationsRCR 2.6